Patent details
EP3129006 Title: IMMUNOSUPPRESSANT FORMULATION
Basic Information
- Publication number:
- EP3129006
- PCT Application Number:
- IB2015052552
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP157357336
- PCT Publication Number:
- WO2015155711
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMMUNOSUPPRESSANT FORMULATION
- French Title of Invention:
- FORMULATION D'IMMUNOSUPPRESSEUR
- German Title of Invention:
- IMMUNSUPPRESSIVE FORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 08/04/2015
- Grant date:
- 27/01/2021
- EP Publication Date:
- 15/02/2017
- PCT Publication Date:
- 15/10/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/01/2021
- EP B1 Publication Date:
- 27/01/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/04/2021
- Expiration date:
- 08/04/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/01/2021
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- REYNAUD, Emeric
- Address:
- Switzerland (CH)
2
- Name:
- BOUILLOT, Philippe Michel Rene
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 201461977806 P
- Priority Date:
- 10/04/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/16; A61K 9/20; A61K 9/28; A61K 31/397;
Publication
European Patent Bulletin
- Issue number:
- 202104
- Publication date:
- 27/01/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|